Smallpox drugmakers surge after monkeypox declared health emergency
25/07/2022 10:53
** Makers of smallpox drugs surge in premarket trading after
the WHO declared the monkeypox outbreak a global health
emergency, the UN agency's highest level of alert urn:newsml:reuters.com:*:nL1N2Z408L
** Monkeypox is a viral infection that causes symptoms
similar to, but milder than, smallpox
** Shares of Siga Technologies SIGA.O , which makes
smallpox treatment tecovirimat or TPOXX, jump 16.3% to $14.14
premarket; TPOXX is available to some clinical trial monkeypox
patients in the United States
** Chimerix Inc CMRX.O shares surge 33.7% to $2.46
premarket; CMRX makes smallpox drug Tembexa and is in the
process of selling the rights to the drug to Emergent
BioSolutions EBS.N
** EBS shares up 9.8% to $34.31 premarket
** Shares of monkeypox vaccine developer GeoVax Labs
GOVX.O jump 32.7% to 84 cents premarket
** Tonix Pharma TNXP.O shares up 13.5% at $1.35; cos
website shows it has a smallpox vaccine in clinical testing
(Reporting by Manas Mishra)
((www.twitter.com/Manaswrites15))